Shaosong Zhang
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shaosong Zhang.
Journal of the American College of Cardiology | 2017
Lei Xing; Takumi Higuma; Zhao Wang; Aaron D. Aguirre; Shaosong Zhang; Bo Yu; Hang Lee; James G. Fujimoto; Valentin Fuster; Ik-Kyung Jang
Background: Lipid-rich plaque (LRP) is thought to be a precursor to cardiac events. The clinical significance of LRP has never been systematically investigated. Methods: A total of 1474 patients undergoing PCI, who had optical coherence tomography (OCT) imaging of the target vessel were included
Journal of the American College of Cardiology | 2015
Yoshiyasu Minami; Jingbo Hou; Haibo Jia; Sining Hu; Rocco Vergallo; Tsunenari Soeda; Shaosong Zhang; Bo Yu; Ik-Kyung Jang
Previous trials demonstrated that lipid-lowering therapies significantly reduced the incidence of major cardiovascular events in patients with coronary artery diseases. However, the gender difference in plaque morphologic change in response to the statin dose remains unclear. From a randomized
Journal of the American College of Cardiology | 2015
Rocco Vergallo; Jingbo Hou; Haibo Jia; Yoshiyasu Minami; Tsunenari Soeda; Sining Hu; Shaosong Zhang; Bo Yu; Ik-Kyung Jang
Large clinical trials demonstrated the benefit of statin therapy in both patients with acute coronary syndrome (ACS) and stable angina pectoris (SAP). However, the vascular response to statin therapy in relation to the clinical presentation is largely unknown. Sixty-nine patients (55 ACS, 14 SAP)
Journal of the American College of Cardiology | 2015
Tsunenari Soeda; Jingbo Hou; Haibo Jia; Sining Hu; Yoshiyasu Minami; Rocco Vergallo; Shaosong Zhang; Bo Yu; Ik-Kyung Jang
Greater plaque burden (PB) is a strong predictor for future coronary event. Therefore, patients with large PB need to be treated aggressively. It is unknown if patients with large PB equally benefit from statin therapy, compared to those with less PB. To evaluate statin effects according to the PB
Journal of the American College of Cardiology | 2015
Sining Hu; Haibo Jia; Rocco Vergallo; Jinwei Tian; Tsunenari Soeda; Yoshiyasu Minami; Lei Gao; Daniel Ong; Hang Lee; Shaosong Zhang; Bo Yu; Ik-Kyung Jang
Emerging evidence suggests in-stent neoatherosclerosis (NA) as an important mechanism for late stent failure. Although statin therapy has been shown beneficial for native vessel atherosclerosis, whether it prevents or delays NA is unknown. We identified 211 patients with 251 stents who underwent
Journal of the American College of Cardiology | 2013
Taishi Yonetsu; Koji Kato; Bo Yu; Shiro Uemura; Haibo Jia; Rocco Vergallo; Farhad Abtahian; Jinwei Tian; Sining Hu; Aaron D. Aguirre; Iris McNulty; Shaosong Zhang; Hang Lee; Ik-Kyung Jang
In vivo detailed distribution of coronary atherosclerotic plaques has not been reported. We sought to obtain detailed morphologic information on plaques in 3 coronary arteries using optical coherence tomography (OCT). Patients with 3 vessel OCT imaging were identified in the OCT registry. Plaques
Journal of the American College of Cardiology | 2013
Haibo Jia; Ning Li; Xuedong Wang; Koji Kato; Taishi Yonetsu; Sining Hu; Jinwei Tian; Shaosong Zhang; Jingbo Hou; Bo Yu; Ik-Kyung Jang
Journal of the American College of Cardiology | 2015
Yoshiyasu Minami; Jingbo Hou; Haibo Jia; Sining Hu; Rocco Vergallo; Tsunenari Soeda; Shaosong Zhang; Bo Yu; Ik-Kyung Jang
Journal of the American College of Cardiology | 2015
Yoshiyasu Minami; Jingbo Hou; Haibo Jia; Sining Hu; Rocco Vergallo; Tsunenari Soeda; Shaosong Zhang; Bo Yu; Ik-Kyung Jang
Journal of the American College of Cardiology | 2013
Rocco Vergallo; Taishi Yonetsu; Stephen Lee; Shiro Uemura; Koji Kato; Haibo Jia; Farhad Abtahian; Jinwei Tian; Sining Hu; Aaron D. Aguirre; Iris McNulty; Hang Lee; Shaosong Zhang; Bo Yu; Italo Porto; Luigi Biasucci; Filippo Crea; Ik-Kyung Jang